DrugCard: Driving Innovations in Pharmacovigilance with AI-Enabled Data Intelligence
Redefine your pharmacovigilance with DrugCard, a multi-lingual, cost-effective AI-enabled platform offering consistent, traceable, and transparent local literature screening solutions for the pharmaceutical industry.
Features
- Intelligent AI-Enabled Platform: DrugCard leverages AI technology and digital advancements to enhance pharmacovigilance processes, making them more efficient, reliable, and accurate.
- Scalable Multi-Lingual Support: Enhance your drug safety globally with our scalable services across markets, supported by over 100+ languages.
- Traceable and Transparent Solutions: Enhance compliance with our transparent and traceable solutions that ensure adherence to regulatory requirements.
Use Cases:
- Outsource Management for CROs: Manage more PV projects, improve screening results, and ensure full compliance with regulatory requirements.
- Local Literature Screening for MAHs: Manage the efficient screening of local and global literature in-house and avoid the nightmare of handling multiple CROs in different countries.
- Saving Time for Freelancers: Free up to 70% of your time for other value-adding activities such as consulting, research, quality assurance, etc.
Stay ahead of the ever-evolving pharmacovigilance challenges with the power of AI automation through DrugCard. Experience 70% time savings, continuous and regular updates, seamless expansion to new markets, and globally compliant, traceable services.
DrugCard Alternatives:
1. PMcardio
PMcardio uses AI to assist in diagnosing and treating cardiovascular diseases via ECG analysis.
2. PharmaTrace
Pharmatrace uses AI and blockchain for efficient chronic disease management and prediction.
4. Lavo
Lavo Life Sciences uses AI to accelerate drug development through chemical simulations.
5. Galenai
GalenAI assists clinicians with AI-powered searches, clinical summaries, and code interpretations.
7. Jadbio
JADBio is a no-code machine learning platform for automated drug discovery.